Literature DB >> 302168

Suppressor T cells prevent experimental autoimmune encephalomyelitis in mice.

C C Bernard.   

Abstract

Immune suppression (immunoprotection) in experimental autoimmune encephalomyelitis (EAE) was studied in (SJL X BALB/c)F1 mice using inocular of mouse spinal cord homogenate (MSCH), or mouse basic protein of myelin (M-BPM), in Freund's incomplete adjuvant (FIA). Such immunization specifically recruited lymphoid cells which markedly suppressed the capacity of effector lymph node cells from appropriately immunized syngeneic mice to transfer adoptively EAE. Suppression was demonstrable with transfer of bone marrow and spleen cells, but not with lymph nodes or thymus cells. Adoptively transferred suppression was maximal when cells were injected 9-30 days after the suppressive injection. Inhibition of EAE by suppressor cells was specific for the relavant antigen BPM, and required viable cells. Treatment of cells with anti-Thy-1 serum before transfer abolished their suppressor activity. After adoptive transfer of suppressor cells into syngeneic recipients subsequently immunized for EAE, there was inhibition of EAE and reduced cell-mediated immune response to BPM as judged by macrophage migration inhibition assays. Hence, in mice at least, immuno-protection against EAE is explicable by recruitment of suppressor T lymphocytes with the dual capacities of inhibiting development of effector T cells after antigenic stimulation, and of blocking their damaging effects on the antigen in the central nervous system.

Entities:  

Mesh:

Year:  1977        PMID: 302168      PMCID: PMC1541041     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  49 in total

1.  Tolerance to an autoantigen-thyroglobulin. Antigen-binding lymphocytes in thymus and blood in health and autoimmune disease.

Authors:  I M Roberts; S Whittingham; I R Mackay
Journal:  Lancet       Date:  1973-10-27       Impact factor: 79.321

2.  Antigen-induced inhibition of experimental allergic encephalomyelitis. II. Studies in guinea pigs with the small rat myelin basic protein.

Authors:  R H Swanborg
Journal:  J Immunol       Date:  1973-10       Impact factor: 5.422

3.  Experimental allergic encephalomyelitis in inbred and outbred mice.

Authors:  S Levine; R Sowinski
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

4.  Suppression of experimental allergic encephalomyelitis by chemically modified encephalitogen.

Authors:  E R Einstein; L P Chao; J Csejtey
Journal:  Immunochemistry       Date:  1972-10

5.  Passive transfer of experimental allergic encephalomyelitis: mechanisms of suppression.

Authors:  G A Falk; M W Kies; E C Alvord
Journal:  J Immunol       Date:  1969-12       Impact factor: 5.422

6.  Protective action of the encephalitogen and other basic proteins in experimental allergic encephalomyelitis.

Authors:  H C Rauch; E R Einstein; J Csejtey; W J Davis
Journal:  Immunochemistry       Date:  1968-11

7.  Inhibition of in vitro cell migration in experimental allergic encephalomyelitis.

Authors:  H C Rauch; R W Ferraresi; S Raffel; E R Einstein
Journal:  J Immunol       Date:  1969-06       Impact factor: 5.422

8.  Lymphocytes binding human thyroglobulin in healthy people and its relevance to tolerance for autoantigens.

Authors:  A D Bankhurst; G Torrigiani; A C Allison
Journal:  Lancet       Date:  1973-02-03       Impact factor: 79.321

9.  Antigen-binding lymphocytes in normal man and guinea pig to human encephalitogenic protein.

Authors:  L L Yung; E Diener; T A McPherson; M A Barton; H A Hyde
Journal:  J Immunol       Date:  1973-05       Impact factor: 5.422

10.  Postthymectomy wasting associated with autoimmune phenomena. I. Antiglobulin-positive anemia in A and C57BL-6 Ks mice.

Authors:  E J Yunis; R Hong; M A Grewe; C Martinez; E Cornelius; R A Good
Journal:  J Exp Med       Date:  1967-05-01       Impact factor: 14.307

View more
  17 in total

1.  A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis.

Authors:  D E Smilek; D C Wraith; S Hodgkinson; S Dwivedy; L Steinman; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

Review 2.  Premises for immune interventional therapy in rheumatoid arthritis.

Authors:  I R Mackay; M J Rowley
Journal:  Postgrad Med J       Date:  1988-07       Impact factor: 2.401

3.  Significance of lymphocytes and blood vessel changes for edema formation in polyradiculoneuritis.

Authors:  R J Seitz; E Neuen-Jacob; W Wechsler
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

4.  Prevention of autoimmune thyroiditis in T cell-depleted rats by injections of crude thyroid extract.

Authors:  D B Whitmore; W J Irvine
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330

5.  Suppression and reversal of allergic encephalomyelitis in rhesus monkeys with basic protein and peptides.

Authors:  E H Eylar; J J Jackson; P J Kniskern
Journal:  Neurochem Res       Date:  1979-04       Impact factor: 3.996

6.  The role of suppressor T cells in the expression of autoimmune haemolytic anaemia in NZB mice.

Authors:  P J Russell; J Cunningham; M Dunkley; N M Wilkinson
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

7.  Experimental allergic encephalomyelitis. Inhibition of clinical signs and paradoxical enhancement of lesions in second attacks.

Authors:  S Levine; R Sowinski
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

8.  Autoimmune thyroiditis: conversion of low-responder mice to high-responders by cyclophosphamide.

Authors:  A O Vladutiu
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

9.  Activation of suppressor function of human peripheral blood T cells by (+)cyanidanol-3: its application to chronic active liver diseases.

Authors:  S Kakumu; H Murakami; J Kuriki
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

10.  Specificity of anti-type II collagen antibody response in rats.

Authors:  K Kakimoto; T Hirofuji; T Koga
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.